Nkx-2.5 Inhibitors
Nkx-2.5 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Nkx-2.5, a homeobox-containing transcription factor that plays a critical role in the regulation of heart development and the maintenance of cardiac function. Nkx-2.5, also known as NK2 homeobox 5, is highly conserved across species and is primarily expressed in the developing and adult heart, where it regulates the expression of genes essential for cardiogenesis, including those involved in the formation of the cardiac conduction system, the differentiation of cardiac myocytes, and the structural integrity of the heart. Nkx-2.5 functions by binding to specific DNA sequences in the promoter regions of its target genes, either activating or repressing their transcription. By inhibiting Nkx-2.5, researchers can disrupt these gene regulatory processes, providing a powerful tool to study the specific contributions of Nkx-2.5 to cardiac development, gene expression, and cellular function.
In research, Nkx-2.5 inhibitors are valuable tools for exploring the molecular mechanisms that underlie heart development and the broader implications of transcription factor regulation on organogenesis and cellular differentiation. By blocking Nkx-2.5 activity, scientists can investigate how the inhibition affects the expression of genes critical for cardiac function, particularly focusing on the role of Nkx-2.5 in the differentiation and maturation of cardiomyocytes, the formation of cardiac structures, and the regulation of the cardiac conduction system. This inhibition allows researchers to study the downstream effects on cardiac morphology, the integrity of heart tissue, and the proper functioning of the heart as a pump. Additionally, Nkx-2.5 inhibitors provide insights into the interactions between Nkx-2.5 and other transcription factors or co-regulators that coordinate the complex gene expression programs required for heart development and maintenance. Through these studies, the use of Nkx-2.5 inhibitors enhances our understanding of the critical role of transcription factors in organ development, the regulation of gene networks during cellular differentiation, and the broader implications of transcriptional control in maintaining tissue-specific functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a chemical inhibitor that indirectly targets Nkx-2.5 by modulating the p38 mitogen-activated protein kinase (MAPK) pathway. By inhibiting p38 MAPK, SB203580 disrupts the signaling cascade, affecting downstream targets, including Nkx-2.5. This disruption can lead to alterations in cellular processes regulated by Nkx-2.5, providing an indirect means of inhibiting its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a chemical inhibitor that indirectly influences Nkx-2.5 by targeting the c-Jun N-terminal kinase (JNK) pathway. Through the inhibition of JNK, SP600125 disrupts the signaling events downstream, potentially impacting Nkx-2.5. The modulation of this pathway can result in alterations in cellular processes regulated by Nkx-2.5, offering an indirect approach to inhibit its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a chemical inhibitor that indirectly affects Nkx-2.5 by targeting the phosphoinositide 3-kinase (PI3K) pathway. Inhibition of PI3K by Wortmannin disrupts downstream signaling events, potentially impacting Nkx-2.5. This interference can lead to modifications in cellular processes regulated by Nkx-2.5, presenting an indirect strategy for inhibiting its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a chemical inhibitor that indirectly modulates Nkx-2.5 by targeting the phosphoinositide 3-kinase (PI3K) pathway. Inhibition of PI3K by LY294002 disrupts downstream signaling events, potentially impacting Nkx-2.5. This interference can lead to modifications in cellular processes regulated by Nkx-2.5, providing an indirect means of inhibiting its activity. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
SP2509 is a chemical inhibitor that indirectly targets Nkx-2.5 by modulating the ubiquitin-proteasome system. By inhibiting specific components of the ubiquitin-proteasome system, SP2509 can potentially affect the degradation or stability of proteins, including those involved in the regulation of Nkx-2.5. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG1478 is a chemical inhibitor that indirectly influences Nkx-2.5 by targeting the epidermal growth factor receptor (EGFR) pathway. Through the inhibition of EGFR, AG1478 disrupts downstream signaling events, potentially impacting Nkx-2.5. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR-99021 is a chemical inhibitor that indirectly targets Nkx-2.5 by modulating the Wnt/β-catenin signaling pathway. By inhibiting glycogen synthase kinase 3β (GSK-3β), CHIR-99021 activates Wnt/β-catenin signaling, potentially influencing Nkx-2.5. This indirect modulation can lead to alterations in cellular processes regulated by Nkx-2.5, offering a unique approach for inhibiting its activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a chemical inhibitor that indirectly targets Nkx-2.5 by modulating the transforming growth factor-beta (TGF-β) signaling pathway. Through the inhibition of TGF-β type I receptor, SB431542 disrupts downstream signaling events, potentially impacting Nkx-2.5. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
GSK690693 is a chemical inhibitor that indirectly modulates Nkx-2.5 by targeting the protein kinase B (Akt) pathway. By inhibiting Akt, GSK690693 disrupts downstream signaling events, potentially impacting Nkx-2.5. This interference can lead to modifications in cellular processes regulated by Nkx-2.5, providing an indirect means of inhibiting its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a chemical inhibitor that indirectly influences Nkx-2.5 by targeting the extracellular signal-regulated kinase (ERK) pathway. Through the inhibition of MEK1/2, PD98059 disrupts downstream signaling events, potentially impacting Nkx-2.5. This interference can lead to modifications in cellular processes regulated by Nkx-2.5, providing an indirect means of inhibiting its activity. | ||||||